Process: |
GO:6355; regulation of transcription, DNA-templated
GO:51092; positive regulation of NF-kappaB transcription factor activity
GO:32479; regulation of type I interferon production
GO:43066; negative regulation of apoptotic process
GO:45892; negative regulation of transcription, DNA-templated
GO:43123; positive regulation of I-kappaB kinase/NF-kappaB signaling
GO:45944; positive regulation of transcription by RNA polymerase II
GO:45893; positive regulation of transcription, DNA-templated
GO:51607; defense response to virus
GO:6954; inflammatory response
GO:10033; response to organic substance
GO:19221; cytokine-mediated signaling pathway
GO:33209; tumor necrosis factor-mediated signaling pathway
GO:8284; positive regulation of cell population proliferation
GO:45087; innate immune response
GO:6357; regulation of transcription by RNA polymerase II
GO:122; negative regulation of transcription by RNA polymerase II
GO:71347; cellular response to interleukin-1
GO:71356; cellular response to tumor necrosis factor
GO:7249; I-kappaB kinase/NF-kappaB signaling
GO:10628; positive regulation of gene expression
GO:32757; positive regulation of interleukin-8 production
GO:71222; cellular response to lipopolysaccharide
GO:1901223; negative regulation of NIK/NF-kappaB signaling
GO:1902894; negative regulation of pri-miRNA transcription by RNA polymerase II
GO:50727; regulation of inflammatory response
GO:1902895; positive regulation of pri-miRNA transcription by RNA polymerase II
GO:2357; defense response to tumor cell
GO:35924; cellular response to vascular endothelial growth factor stimulus
GO:70301; cellular response to hydrogen peroxide
GO:70498; interleukin-1-mediated signaling pathway
GO:70555; response to interleukin-1
GO:43620; regulation of DNA-templated transcription in response to stress
GO:71223; cellular response to lipoteichoic acid
GO:1902004; positive regulation of amyloid-beta formation
GO:1901224; positive regulation of NIK/NF-kappaB signaling
GO:1904996; positive regulation of leukocyte adhesion to vascular endothelial cell
GO:34097; response to cytokine
GO:2000630; positive regulation of miRNA metabolic process
GO:2001237; negative regulation of extrinsic apoptotic signaling pathway
GO:10224; response to UV-B
GO:71316; cellular response to nicotine
GO:71354; cellular response to interleukin-6
GO:1904385; cellular response to angiotensin
GO:6968; cellular defense response
GO:50862; positive regulation of T cell receptor signaling pathway
GO:7218; neuropeptide signaling pathway
GO:1901222; regulation of NIK/NF-kappaB signaling
GO:38061; NIK/NF-kappaB signaling
GO:70431; nucleotide-binding oligomerization domain containing 2 signaling pathway
GO:1889; liver development
GO:1942; hair follicle development
GO:6325; chromatin organization
GO:6351; transcription, DNA-templated
GO:6952; defense response
GO:9617; response to bacterium
GO:9887; animal organ morphogenesis
GO:32495; response to muramyl dipeptide
GO:32735; positive regulation of interleukin-12 production
GO:33234; negative regulation of protein sumoylation
GO:35729; cellular response to hepatocyte growth factor stimulus
GO:35994; response to muscle stretch
GO:42177; negative regulation of protein catabolic process
GO:71224; cellular response to peptidoglycan
GO:99527; postsynapse to nucleus signaling pathway
GO:1901522; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus
GO:10468; regulation of gene expression
|